陈绍良入选中国工程院2025年院士增选有效候选人：从原创术式到国际认可，中国心血管学科的突破之路

Core Viewpoint - The selection of Chen Shaoliang as a candidate for the Chinese Academy of Engineering highlights the growing recognition of Chinese medical professionals in the field of cardiovascular intervention, reflecting the country's emphasis on original medical innovations and high-end medical device localization [1][5]. Group 1: Candidate Selection - The Chinese Academy of Engineering announced a total of 660 valid candidates for the 2025 academician election, with 91 candidates from the Medical and Health Sciences Division [1]. Group 2: Professional Achievements - Chen Shaoliang has made significant contributions to clinical, research, and educational work in cardiology, holding important academic positions in various prestigious organizations such as the American College of Cardiology (ACC) and the European Society of Cardiology (ESC) [3]. - He has published over 300 SCI-indexed papers and has been recognized as one of the most cited scholars in the Chinese cardiovascular field, with some papers cited over a thousand times [4]. Group 3: Innovations and Contributions - Chen's innovative techniques, such as the "DK CRUSH" method for treating coronary bifurcation lesions, have gained international recognition, being included in global guidelines by the European Society of Cardiology [3][4]. - His work on the percutaneous pulmonary artery denervation (PADN) technique was incorporated into the ESC/ERS guidelines for pulmonary hypertension, marking a significant achievement for Chinese medical innovation [4]. Group 4: Alignment with National Policies - Chen's achievements align with national strategies like "Healthy China 2030" and "Technological Self-Reliance," showcasing a complete innovation path from clinical needs to international guideline recognition and industrial transformation [5]. - His selection as a candidate not only acknowledges his personal contributions but also reflects the rising global influence of Chinese medical innovations [5].